.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Cerilliant
Julphar
UBS
Covington
Chinese Patent Office
Deloitte
AstraZeneca
Healthtrust

Generated: December 16, 2017

DrugPatentWatch Database Preview

PENTOLAIR Drug Profile

« Back to Dashboard

When do Pentolair patents expire, and when can generic versions of Pentolair launch?

Pentolair is a drug marketed by Bausch And Lomb and Pharmafair and is included in three NDAs.

The generic ingredient in PENTOLAIR is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
Drug patent expirations by year for PENTOLAIR

Medical Subject Heading (MeSH) Categories for PENTOLAIR

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And LombPENTOLAIRcyclopentolate hydrochlorideSOLUTION/DROPS;OPHTHALMIC040075-001Apr 29, 1994ATRXNoNo► Subscribe► Subscribe► Subscribe
PharmafairPENTOLAIRcyclopentolate hydrochlorideSOLUTION/DROPS;OPHTHALMIC088643-001Feb 9, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
PharmafairPENTOLAIRcyclopentolate hydrochlorideSOLUTION/DROPS;OPHTHALMIC088150-001Feb 25, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Healthtrust
McKesson
Merck
Fish and Richardson
US Army
Chinese Patent Office
Mallinckrodt
Medtronic
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot